Rapid Biotech Platform Strategies

Develop a comparative analysis of platform-based biotech strategies (e.g., modular vaccine or therapeutic platforms) designed for rapid response to viral threats. Discuss regulatory pathways, supply chain resilience, international collaboration, intellectual property considerations, and equity in access. Propose an actionable plan for evaluating platform readiness, risk management, and public communication in a way that informs policymakers, funders, and researchers about potential timelines and bottlenecks without focusing on a single pathogen.